PRTA FY 2014 Earnings — Prothena Corporation plc Revenue & Financial Results | Market Cap Arena

PRTAProthena Corporation plc

$516M

FY 2014 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$51M+7422.8% YoY

Gross Profit

$12M24.4% margin

Operating Income

-$7M-13.1% margin

Net Income

-$7M-14.1% margin

EPS (Diluted)

$-0.29

Cash Flow

Operating Cash Flow

-$683,000

Free Cash Flow

-$1M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$304M

Total Liabilities

$14M

Stockholders' Equity

$290M

Cash & Equivalents

$294M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$51M	$676,000	+7422.8%
Gross Profit	$12M	-$25M	+148.9%
Operating Income	-$7M	-$40M	+83.6%
Net Income	-$7M	-$41M	+82.6%